1. Efficacy of the Kyoto Classification of Gastritis in Identifying Patients at High Risk for Gastric Cancer
- Author
-
Taketo Otsuka, Akira Andoh, Shigeki Bamba, Mitsushige Sugimoto, Osamu Inatomi, Hiromitsu Ban, Takahisa Furuta, Hitomi Ichikawa, and Shu Sahara
- Subjects
Male ,medicine.medical_specialty ,Gastroenterology ,Muscle hypertrophy ,Helicobacter Infections ,03 medical and health sciences ,0302 clinical medicine ,Atrophy ,Risk Factors ,Stomach Neoplasms ,Internal medicine ,Internal Medicine ,Prevalence ,Medicine ,Humans ,mass screening/MT ,Aged ,Metaplasia ,biology ,Helicobacter pylori ,business.industry ,gastric cancer ,Intestinal metaplasia ,Cancer ,risk assessment ,General Medicine ,Odds ratio ,Middle Aged ,biology.organism_classification ,medicine.disease ,Confidence interval ,Gastric Mucosa ,030220 oncology & carcinogenesis ,Gastritis ,030211 gastroenterology & hepatology ,Original Article ,Female ,medicine.symptom ,business - Abstract
Objective The Kyoto gastritis classification categorizes the endoscopic characteristics of Helicobacter pylori (H. pylori) infection-associated gastritis and identifies patterns associated with a high risk of gastric cancer. We investigated its efficacy, comparing scores in patients with H. pylori-associated gastritis and with gastric cancer. Methods A total of 1,200 patients with H. pylori-positive gastritis alone (n=932), early-stage H. pylori-positive gastric cancer (n=189), and successfully treated H. pylori-negative cancer (n=79) were endoscopically graded according to the Kyoto gastritis classification for atrophy, intestinal metaplasia, fold hypertrophy, nodularity, and diffuse redness. Results The prevalence of O-II/O-III-type atrophy according to the Kimura-Takemoto classification in early-stage H. pylori-positive gastric cancer and successfully treated H. pylori-negative cancer groups was 45.1%, which was significantly higher than in subjects with gastritis alone (12.7%, p
- Published
- 2017